Investigation of Vascular Pathology in Eye Diseases Using Using Optical Coherence Tomography Angiography (OCT-A)

NCT ID: NCT02811536

Last Updated: 2022-11-29

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

440 participants

Study Classification

OBSERVATIONAL

Study Start Date

2017-02-13

Study Completion Date

2022-11-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of OCTA to conventional imaging modalities for the diagnosis of eye diseases

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Optical coherence tomography angiography (OCTA) is a new non-invasive imaging technique that employs motion contrast imaging to high-resolution volumetric blood flow information. OCTA compares the decorrelation signal between sequential OCT b-scans taken at precisely the same cross-section in order to construct a map of blood flow. At present, level 1 evidence of the technology's clinical applications doesn't exist. The investigators plan to compare OCTA as an imaging modality to conventional imaging modalities used in clinical routine.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Retinal Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Diabetic retinopathy

Patients with various degrees of diabetic retinopathy

optical coherence tomography angiography

Intervention Type DEVICE

Imaging with optical coherence tomography angiography

Retinal detachment

Patients with a history of retinal detachment

optical coherence tomography angiography

Intervention Type DEVICE

Imaging with optical coherence tomography angiography

Retinal vein occlusion

Patients with a history of retinal vein occlusion

optical coherence tomography angiography

Intervention Type DEVICE

Imaging with optical coherence tomography angiography

Arterial hypertension

Patients with a history of arterial hypertension

optical coherence tomography angiography

Intervention Type DEVICE

Imaging with optical coherence tomography angiography

Carotid artery occlusion

Patients with a history of carotid artery occlusion

optical coherence tomography angiography

Intervention Type DEVICE

Imaging with optical coherence tomography angiography

Age related macular degeneration

Patients with a history of Age related macular degeneration

optical coherence tomography angiography

Intervention Type DEVICE

Imaging with optical coherence tomography angiography

Macroaneurysms

Patients with a history of retinal macroaneurysms

optical coherence tomography angiography

Intervention Type DEVICE

Imaging with optical coherence tomography angiography

Central serous chorioretinopathy

Patients with a history of central serous chorioretinopathy

optical coherence tomography angiography

Intervention Type DEVICE

Imaging with optical coherence tomography angiography

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

optical coherence tomography angiography

Imaging with optical coherence tomography angiography

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Patients from the Department of Ophthalmology, University Hospital Bern requiring conventional imaging for eye disease and willing to sign informed consent Patients of 18 years or older

Exclusion Criteria

Patients not willing or able to sign informed consent Patients younger than 18 years Patients with epilepsy Patients having had photodynamic therapy within the last 48 hours prior to imaging with OCTA
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Insel Gruppe AG, University Hospital Bern

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Martin Zinkernagel, Prof.MD PhD

Role: STUDY_CHAIR

Inselspital, University Clinic for Ophthalmology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Inselspital Bern, Department of Ophthalmology

Bern, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Tian M, Zeng G, Zinkernagel M, Tappeiner C, Wolf S, Munk MR. Assessment of choriocapillaris and choroidal vascular changes in posterior uveitis using swept-source wide-field optical coherence tomography angiography. Br J Ophthalmol. 2024 Feb 21;108(3):386-390. doi: 10.1136/bjo-2022-322209.

Reference Type DERIVED
PMID: 36627172 (View on PubMed)

Tian M, Tappeiner C, Zinkernagel MS, Huf W, Wolf S, Munk MR. Evaluation of vascular changes in intermediate uveitis and retinal vasculitis using swept-source wide-field optical coherence tomography angiography. Br J Ophthalmol. 2019 Sep;103(9):1289-1295. doi: 10.1136/bjophthalmol-2018-313078. Epub 2018 Dec 11.

Reference Type DERIVED
PMID: 30538102 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

OCTA Bern

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Adaptive Optics Retinal Imaging
NCT02317328 RECRUITING
Dual Wavelength OCT
NCT03843840 COMPLETED
High Resolution Imaging OCT Study
NCT07338461 NOT_YET_RECRUITING NA